Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial Images
Generic Name: efgartigimod alfa/hyaluronidase
This medication has been identified as Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial. It is supplied by argenx US, Inc.
Vyvgart Hytrulo is used in the treatment of Myasthenia Gravis; Chronic Inflammatory Demyelinating Polyradiculoneuropathy and belongs to the drug class immune globulins. Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vyvgart Hytrulo
- Generic Name
- efgartigimod alfa/hyaluronidase
- Strength
- efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- Immune globulins
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- argenx US, Inc.
- Manufacturer
- Halozyme Therapeutics, Inc.
- National Drug Code (NDC)
- 73475-3102
More about Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
